Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy

NCT03993249 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: Nivolumab
OTHER: chemoradiotherapy

Sponsor

Hellenic GenitoUrinary Cancer Group